Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Buy
+782
New +$91.5K 0.01% 71
2023
Q4
Sell
-7,500
Closed -$772K 81
2023
Q3
$772K Buy
+7,500
New +$808K 0.47% 56
2023
Q1
Sell
-7,000
Closed -$777K 92
2022
Q4
$777K Sell
7,000
-6,700
-49% -$685K 0.38% 59
2022
Q3
$1.18M Buy
+13,700
New +$1.22M 0.87% 6
2021
Q4
Sell
-5,600
Closed -$421K 88
2021
Q3
$421K Buy
+5,600
New +$426K 0.05% 23
2021
Q2
Sell
-12,786
Closed -$940K 85
2021
Q1
$940K Buy
+12,786
New +$943K 0.08% 71
2020
Q4
Sell
-12,262
Closed -$971K 88
2020
Q3
$971K Buy
+12,262
New +$960K 0.29% 97
2020
Q2
Sell
-11,528
Closed -$846K 76
2020
Q1
$846K Buy
+11,528
New +$906K 0.77% 47
2019
Q1
Sell
-14,148
Closed -$1.03M 74
2018
Q4
$1.03M Buy
+14,148
New +$999K 0.45% 43

Other funds holding MRK

Toews Corporation's MRK Position: Q2 2026 in Review

Toews Corporation opened a new position in Merck (MRK) in Q2 2026: 782 shares worth $100K. The stake represents 0.01% of the portfolio and ranks #71 among its holdings. This is a return to the name: Toews Corporation previously reported a position in MRK as recently as Q3 2023.

Toews Corporation first reported a position in MRK in Q4 2018 and has held it in 9 quarters since. The position peaked at $1.18M in Q3 2022. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Toews Corporation held 782 shares of Merck worth $100K as of Q2 2026.
  • Merck was a new Toews Corporation position in Q2 2026.
  • Merck made up 0.01% of Toews Corporation's portfolio in Q2 2026, its #71 holding.
  • Toews Corporation first reported a position in Merck in Q4 2018 and has held it in 9 quarters since.
  • Toews Corporation's Merck position peaked at $1.18M in Q3 2022.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Toews Corporation's 13F filing for Q2 2026, filed 10 Aug 2026.